JUL 20, 2016 12:06 PM PDT

Scientists One Step Closer to a Brain Window, Literally

WRITTEN BY: Xuan Pham
Wouldn’t it be nice if brain surgeons had a window to your brain? Well, scientists at the University of California, Riverside (UCR) are taking this expression literally, and they are building just that: a biocompatible “window to the brain.”
A biocompatible "window to the brain" | Image: UC Riverside
To treat brain injuries, brain cancer, and other conditions associated with this organ, surgeons often have to crack open the skull – a procedure known as a craniotomy. This procedure is extremely invasive and high-risk, as the brain is exposed to potential bacteria in the hospital. Indeed, the authors report that "bacterial adhesion to the cranial implant is the leading factor for biofilm formation (fouling), infection, and treatment failure." And for patients who require more than one brain surgery, each repeated craniotomy likely multiplies the odds of infection.

Thus, the purpose of such a clear skull implant is to minimize the number of times surgeons have to open the skull. Using lasers that penetrate the transparent skull implant, surgeons could see their target and treat the condition on demand. The transparent implant could also potentially shorten the surgery time for patients, as the brain is more readily accessible to surgeons.

Though previous researchers have worked towards a transparent skull implant, UCR scientists innovated the use of a new biocompatible ceramic material known as yttria-stabilized zirconia (YSZ). This material has several advantages, one of which is its high impact resistance. This is why YSZ has been commonly used in hip implants and dental crowns. In addition, it’s also why glass, though clear, is not a viable material due to its shatter-prone qualities.

"The YSZ was actually found to be more biocompatible than currently available materials, such as titanium or thermo-plastic polymers, so this was another piece of good news in our development of transparent YSZ as the material of choice for cranial implants," said Guillermo Aguilar, professor of mechanical engineering at UCR's Bourns College of Engineering, and senior author of the study.
But what doctors value even more than its toughness is YSZ’s ability to curb brain infections. In their latest lab tests, the UCR team reported that laser treatment killed E. coli biofilms on the surface of the YSZ implant, without removing the implant and damaging other tissues.

Given that bacterial biofilms are among the biggest scourges in hospitals, doctors are especially wary about implants in the brain causing infections. Already brain infections are incredibly high risk as many bacteria are fast becoming resistant to antibiotics. And among the antibiotics that still work, some can’t cross the blood-brain barrier. In particular, E. coli is the notorious culprit behind meningitis in patients who have brain surgery.

“This was an important finding because it showed that the combination of our transparent implant and laser-based therapies enables us to treat not only brain disorders, but also to tackle bacterial infections that are common after cranial implants. These infections are especially challenging to treat because many antibiotics do not penetrate the blood brain barrier,” said Devin Binder, a neurosurgeon and neuroscientist at UCR’s School of Medicine, and a collaborator on the project.
 

Additional source: UCR press release
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 18, 2020
Clinical & Molecular DX
DIY COVID Tests Instead of Vaccines?
AUG 18, 2020
DIY COVID Tests Instead of Vaccines?
Routine, do-it-yourself COVID-19 testing could be just as good as a vaccine when it comes to stopping the transmission o ...
SEP 17, 2020
Coronavirus
A Biomarker May Predict the Most Severe COVID-19 Cases
SEP 17, 2020
A Biomarker May Predict the Most Severe COVID-19 Cases
Researchers may have found a way to identify the COVID-19 patients that will need targeted therapies the most.
OCT 17, 2020
Clinical & Molecular DX
Imaging Innovation Set to Ease the Pain of Osteoarthritis
OCT 17, 2020
Imaging Innovation Set to Ease the Pain of Osteoarthritis
In osteoarthritis, the joint cartilage that cushions bones begins to break down, causing debilitating pain and stiffness ...
OCT 21, 2020
Cancer
Can Excess Fructose Cause Liver Cancer?
OCT 21, 2020
Can Excess Fructose Cause Liver Cancer?
Hepatocellular carcinoma, aka liver cancer, is an ever-increasing issue in the western world. While the lion’s sha ...
NOV 15, 2020
Neuroscience
Hearing Test Can Predict Autism in Newborns
NOV 15, 2020
Hearing Test Can Predict Autism in Newborns
For some time now, researchers have been aware that children and adults with autism tend to have different sensory syste ...
NOV 18, 2020
Clinical & Molecular DX
Nerve Damage as a Prognostic Marker for Rare Autoimmune Disease
NOV 18, 2020
Nerve Damage as a Prognostic Marker for Rare Autoimmune Disease
Researchers have identified a new prognostic biomarker for Guillain-Barré syndrome (GBS), a rare autoimmune disor ...
Loading Comments...